Trial Profile
Effect of vildagliptin versus glimepiride on glycemic control, inflammatory markers and fat tolerance in patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2015
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 14 May 2015 New trial record